UK consultant Turner & Townsend (T&T) has announced a move into life sciences with a partnership with American firm Taurus Project Consulting.
Turner & Townsend Taurus will operate from Taurus’ head office in Boston, and will focus on healthcare and pharmaceutical industries. According to T&T, the partnership’s client list includes half of the major pharmaceutical businesses worldwide.
John Robbins, T&T US’ managing director, said: "The life sciences sector continues to see exponential growth, as healthcare spending soars in the US and across global regions. This brings opportunities but also challenges the major players in the industry as they seek to manage their real estate assets in a way that accelerates performance.   Â
"This merger will build on the expertise of both teams to support clients navigating this fast-paced commercial environment – bringing together Taurus’ work in project controls alongside T&T’s own experience and global reach."
Jason Haskell, Taurus’ president, said: "Our partnership will bring major opportunities to expand our service offer to clients, deploying T&T’s expertise in project, cost and programme management as well as its focus on lifetime asset management.
"Culturally, we share an ambition of growth to best support clients’ commercial objectives and also our people – ensuring they have the right skills and digital tools available to deliver world-class results. We are incredibly excited about this new chapter for our team."
T&T employs 600 people in 14 offices across America.
Image: Boston (Public Domain)
